BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2051004)

  • 1. A randomised double-blind placebo-controlled trial of prednisolone therapy in HBeAg and HBV DNA positive Chinese patients with chronic active hepatitis B.
    Lee SD; Tong MJ; Wu JC; Lin HC; Tsai YT; Lo KJ
    J Hepatol; 1991 Mar; 12(2):246-50. PubMed ID: 2051004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short report: prednisolone withdrawal followed by lymphoblastoid interferon in the therapy of adult patients with presumed childhood-acquired chronic hepatitis B virus infection.
    Brook MG; Main J; Yap I; Chan G; Karayiannis P; Crossey M; Thomas HC
    Aliment Pharmacol Ther; 1993 Jun; 7(3):331-6. PubMed ID: 8364139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial Group.
    Krogsgaard K; Marcellin P; Trepo C; Berthelot P; Sanchez-Tapias JM; Bassendine M; Tran A; Ouzan D; Ring-Larsen H; Lindberg J; Enriquez J; Benhamou JP; Bindslev N
    J Hepatol; 1996 Dec; 25(6):803-13. PubMed ID: 9007706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Three year adefovir dipivoxil treatment for hepatitis B e antigen-positive chronic hepatitis B patients].
    Ling N; Zhou Z; Zhang DZ; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):346-9. PubMed ID: 17524266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triiodothyronine level and triiodothyronine/thyroxine ratio in HBeAg-positive chronic hepatitis patients treated with prednisolone withdrawal.
    Itoh S; Matsuo S; Oda T; Marutani K; Sasaki K
    Dig Dis Sci; 1990 Sep; 35(9):1110-4. PubMed ID: 2390925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
    Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
    Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of short-term prednisolone therapy in patients with severe chronic type B hepatitis.
    Yoo JY; Kim HY; Park CK; Shim KS; Chung WK
    Korean J Intern Med; 1989 Jan; 4(1):80-5. PubMed ID: 2487409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of hepatitis B virus DNA in anti-HBe positive sera on longitudinal follow-up of patients with renal transplants and chronic hepatitis B.
    Norder H; Brattström C; Magnius L
    J Med Virol; 1989 Apr; 27(4):322-8. PubMed ID: 2656911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous reactivation of hepatitis B virus replication in HBsAg carriers who seroconverted from HBeAg to anti-HBe.
    Okuno T; Takeda M; Matsumoto M; Shindo M; Arai K; Takino T
    Jpn J Med; 1989; 28(1):45-9. PubMed ID: 2724647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cianidanol therapy for HBe-antigen-positive chronic hepatitis: a multicentre, double-blind study.
    Suzuki H; Yamamoto S; Hirayama C; Takino T; Fujisawa K; Oda T
    Liver; 1986 Feb; 6(1):35-44. PubMed ID: 3520204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disappearance of serum hepatitis B virus DNA by polymerase chain reaction after adenine arabinoside 5'-monophosphate therapy in chronic hepatitis B.
    Buti M; Rodriguez-Frias F; Genesca J; Arranz A; Jardi R; Esteban R; Guardia J
    Liver; 1993 Jun; 13(3):136-40. PubMed ID: 7687734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial.
    Chan HL; Wang H; Niu J; Chim AM; Sung JJ
    Antivir Ther; 2007; 12(3):345-53. PubMed ID: 17591024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group.
    Tassopoulos NC; Volpes R; Pastore G; Heathcote J; Buti M; Goldin RD; Hawley S; Barber J; Condreay L; Gray DF
    Hepatology; 1999 Mar; 29(3):889-96. PubMed ID: 10051494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
    Hasan KN; Rumi MA; Hasanat MA; Azam MG; Ahmed S; Salam MA; Islam LN; Hassan MS
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term prednisolone for inducing seroconversion from hepatitis B e antigen to antibody along with clinical improvement in patients with chronic active hepatitis type B.
    Kumada H; Ikeda K; Yoshida A; Seto S; Tsukada T; Kojima M; Suzuki H; Mayumi M
    Jpn J Med; 1987 May; 26(2):217-22. PubMed ID: 3626161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectivity in asymptomatic hepatitis B carriers: its correlation with HBeAg/anti-HBe status.
    Cheng NY; Chang JG; Liao ST; Liu JD; Lee LS; Chen PH; Choo KB
    Taiwan Yi Xue Hui Za Zhi; 1989 Feb; 88(2):148-51. PubMed ID: 2769214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HBe antigen and B virus DNA in patients with chronic active hepatitis].
    Chaussade S; Thiers V; Boboc B; Housset C; Bréchot C; Degos F
    Gastroenterol Clin Biol; 1986 Nov; 10(11):744-7. PubMed ID: 3803809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicentre randomized clinical trial of recombinant alpha-2a interferon therapy in patients with chronic hepatitis B.
    Rumi M; Romeo R; De Filippi F; Marcelli R; Del Ninno E; van Eyken P; Desmet V; Colombo M
    Ital J Gastroenterol; 1993 Apr; 25(3):117-20. PubMed ID: 8507888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.